301 related articles for article (PubMed ID: 29668588)
21. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
Kannankeril PJ; Moore JP; Cerrone M; Priori SG; Kertesz NJ; Ro PS; Batra AS; Kaufman ES; Fairbrother DL; Saarel EV; Etheridge SP; Kanter RJ; Carboni MP; Dzurik MV; Fountain D; Chen H; Ely EW; Roden DM; Knollmann BC
JAMA Cardiol; 2017 Jul; 2(7):759-766. PubMed ID: 28492868
[TBL] [Abstract][Full Text] [Related]
22. Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.
Bergeman AT; Wilde AAM; van der Werf C
Card Electrophysiol Clin; 2023 Sep; 15(3):293-305. PubMed ID: 37558300
[TBL] [Abstract][Full Text] [Related]
23. Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.
Heiner JD; Bullard-Berent JH; Inbar S
Pediatr Emerg Care; 2011 Nov; 27(11):1065-8. PubMed ID: 22068070
[TBL] [Abstract][Full Text] [Related]
24. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
[TBL] [Abstract][Full Text] [Related]
25. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
Garabedian L; Verryckt A; Panzer J; De Wolf D
Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993
[TBL] [Abstract][Full Text] [Related]
26. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
[TBL] [Abstract][Full Text] [Related]
27. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
[TBL] [Abstract][Full Text] [Related]
28. Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia.
Yan Y; Tang L; Wang X; Zhou K; Hu F; Duan H; Liu X; Hua Y; Wang C
Orphanet J Rare Dis; 2023 Dec; 18(1):380. PubMed ID: 38053087
[TBL] [Abstract][Full Text] [Related]
29. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
Pflaumer A; Davis AM
Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.
Andrsova I; Valaskova I; Kubus P; Vit P; Gaillyova R; Kadlecova J; Manouskova L; Novotny T
Pacing Clin Electrophysiol; 2012 Jul; 35(7):798-803. PubMed ID: 22519458
[TBL] [Abstract][Full Text] [Related]
32. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
Sumitomo N; Harada K; Nagashima M; Yasuda T; Nakamura Y; Aragaki Y; Saito A; Kurosaki K; Jouo K; Koujiro M; Konishi S; Matsuoka S; Oono T; Hayakawa S; Miura M; Ushinohama H; Shibata T; Niimura I
Heart; 2003 Jan; 89(1):66-70. PubMed ID: 12482795
[TBL] [Abstract][Full Text] [Related]
33. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
[TBL] [Abstract][Full Text] [Related]
34. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
Watanabe H; van der Werf C; Roses-Noguer F; Adler A; Sumitomo N; Veltmann C; Rosso R; Bhuiyan ZA; Bikker H; Kannankeril PJ; Horie M; Minamino T; Viskin S; Knollmann BC; Till J; Wilde AA
Heart Rhythm; 2013 Apr; 10(4):542-7. PubMed ID: 23286974
[TBL] [Abstract][Full Text] [Related]
35. Catecholaminergic Polymorphic Ventricular Tachycardia.
Wall JJ; Iyer RV
Pediatr Emerg Care; 2017 Jun; 33(6):427-431. PubMed ID: 28570361
[TBL] [Abstract][Full Text] [Related]
36. Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation.
Paech C; Gebauer RA; Karstedt J; Marschall C; Bollmann A; Husser D
Pediatr Cardiol; 2014 Dec; 35(8):1437-41. PubMed ID: 24950728
[TBL] [Abstract][Full Text] [Related]
37. [Catecholaminergic polymorphic ventricular tachycardia; possible diagnosis in cases of syncope and sudden death of family members].
Lieve KV; Wilde AA; van der Werf C
Ned Tijdschr Geneeskd; 2015; 159():A8205. PubMed ID: 25650029
[TBL] [Abstract][Full Text] [Related]
38. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
Campbell MJ; Czosek RJ; Hinton RB; Miller EM
Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review.
Leung J; Lee S; Zhou J; Jeevaratnam K; Lakhani I; Radford D; Coakley-Youngs E; Pay L; Çinier G; Altinsoy M; Behnoush AH; Mahmoudi E; Matusik PT; Bazoukis G; Garcia-Zamora S; Zeng S; Chen Z; Xia Y; Liu T; Tse G
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 35892906
[TBL] [Abstract][Full Text] [Related]
40. Catecholaminergic polymorphic ventricular tachycardia.
Liu N; Ruan Y; Priori SG
Prog Cardiovasc Dis; 2008; 51(1):23-30. PubMed ID: 18634915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]